Richard Burt, MD
Professor of Medicine
Chief, Division of Immunotherapy for Autoimmune Diseases
The Division of Immunotherapy for Autoimmune Diseases (DIAD) is laboratory and clinic based, utilizing methods that allow the safe isolation, manipulation, and preservation of populations of stem cells and immune cells for therapeutic purposes. Currently DIAD collaborates with the Divisions of Rheumatology, Nephrology, Gastroenterology, and Hematology/Oncology, and the Departments of Neurology and Transplant Surgery in innovative approaches and active protocols for the treatment of severe lupus, amyloidosis, multiple scleroses, rheumatoid arthritis and post transplant lymphoproliferative disorders, and cancers. It is funded by grants from the National Institutes of Health and Leukemia Society of America, as well as a generous philanthropic donation and its own clinical revenues. The Division invites inquiries from physicians who would like to apply hematopoietic stem cells or immune cells toward innovative approaches to disease management and organ regeneration.